glp 1 drugs available in usa You've reached your weight loss goal on GLP-1 medications – what now? The GLP-1 Access Gap: Mapping
Description
The main incretins are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)

Tirzepatide: a review in type 2 diabetes
doi:10.1152/ajpendo.00143.2016 40
[DOI] [PubMed] [Google Scholar] 250
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
N Engl J Med 385(16):14511461
GLP-1 treatment was not statistically significantly different compared to control at reducing the risk of developing dry AMD at one and three years after treatment, but GLP-1 receptor agonists did lower dry AMD risk at five and 10 years after treatment by 9.2% and 14.9%, respectively
